Business
Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directors
Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directors
About this update from Resverlogix Corp.
[{"type":"text","content":"\n\n\n\nFeb. 1, 2010 (Canada NewsWire Group) -- CALGARY, Feb. 1 /CNW/ -- Resverlogix Corp. (\"Resverlogix\" or the \"Company\") (TSX:RVX) announced today that the Board of Directors has elected Arthur J. Higgins, CEO of Bayer HealthCare and Chairman of the Bayer HealthCare Executive Committee, to the Board effective February 1, 2010.Mr. Higgins joined Bayer in 2004 as Chairman of the Bayer HealthCare Executive Committee and in 2006 was named Chairman of the Board of Management of Bayer HealthCare. Mr. Higgins has played a key role in driving the success of Bayer HealthCare through a combination of strong organic growth and key acquisitions, including the (euro)17 billion acquisition of the German pharmaceutical company, Schering AG, in 2006.\"Arthur Higgins' global leadership experience and exposure to numerous healthcare markets are just a few of the reasons that he is a valued addition to the Board,\" said Donald J. McCaffrey, President & CEO of Resverlogix. \"As we progress through our Phase 2 clinical trials, we welcome Mr. Higgins' perspective as a strategist and R&D specialist.\"Mr. Higgins was born in Airdrie, Scotland. He studied at Scotland's Strathclyde University from 1974 to 1978, where he gained a Bachelor of Science degree in biochemistry.Mr. Higgins started his career in 1978 in England with Bristol-Myers. He subsequently worked for Sandoz (1979 to 1984) and Fisons (1984 to 1987) before moving to Abbott Laboratories in the USA (1987 to 2001), where he held various positions of increasing responsibility in the international and domestic divisions, including a two-year posting in Germany. He was appointed President of the Pharmaceutical Products Division in Chicago, Illinois, USA, in 1998. In this position, he was in charge of Abbott's pharmaceuticals business in the United States with responsibility for global pharmaceutical research and development.In 2001, Mr. Higgins was appointed Chairman and CEO of Enzon Pharmaceuticals headquartered in Bridgewater, New Jersey, USA. In this function, he also served as Chairman of the Biotech Council of New Jersey and on the board of the U.S. National Pharmaceutical Council.Mr. Higgins represents Bayer in the Executive Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA), and is also a member of the Council of the International Federation of Pharmaceuti...